Abstract
Human mesenchymal stem cells (hMSCs), a type of adult stem cells that hold great potential in clinical applications (e.g., regenerative medicine and cell-based therapy) due to their ability to differentiate into multiple types of specialized cells and secrete soluble factors which can initiate tissue repair and regulate immune response. hMSCs need to be expanded in vitro or cryopreserved to obtain sufficient cell numbers required for clinical applications. However, long-term in vitro culture-expanded hMSCs may raise some biosafety concerns (e.g., chromosomal abnormality and malignant transformation) and compromised functional properties, limiting their use in clinical applications. To avoid those adverse effects, it is essential to cryopreserve hMSCs at early passage and pool them for off-the-shelf use in clinical applications. However, the existing cryopreservation methods for hMSCs have some notable limitations. To address these limitations, several approaches have to be taken in order to produce healthy and efficacious cryopreserved hMSCs for clinical trials, which remains challenging to date. Therefore, a noteworthy amount of resources has been utilized in research in optimization of the cryopreservation methods, development of freezing devices, and formulation of cryopreservation media to ensure that hMSCs maintain their therapeutic characteristics without raising biosafety concerns following cryopreservation. Biobanking of hMSCs would be a crucial strategy to facilitate clinical applications in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- hMSCs:
-
Human mesenchymal stem cells
- CPA:
-
Cryoprotective agent
- DMSO:
-
Dimethyl sulfoxide
- FBS:
-
Fetal bovine serum
- GvHD:
-
Graft-versus-host disease
References
Heathman TR, Glyn VA, Picken A, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ (2015) Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng 112(8):1696–1707
Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076–1084
Doulatov S, Daley GQ (2013) Development. A stem cell perspective on cellular engineering. Science 342(6159):700–702
Choi JR, Pingguan-Murphy B, Wan Abas WA, Noor Azmi MA, Omar SZ, Chua KH, Wan Safwani WK (2014) Impact of low oxygen tension on stemness, proliferation and differentiation potential of human adipose-derived stem cells. Biochem Biophys Res Commun 448(2):218–224
Choi JR, Pingguan-Murphy B, Abas WABW, Azmi MAN, Omar SZ, Chua KH, Safwani WKZW (2014) Hypoxia promotes growth and viability of human adipose-derived stem cells with increased growth factors secretion. J Asian Sci Res 4(7):328–338
Lindroos B, Suuronen R, Miettinen S (2011) The potential of adipose stem cells in regenerative medicine. Stem Cell Rev 7(2):269–291
Callihan P, Mumaw J, Machacek DW, Stice SL, Hooks SB (2011) Regulation of stem cell pluripotency and differentiation by G protein coupled receptors. Pharmacol Ther 129(3):290–306
Choi JR, Pingguan-Murphy B, Wan Abas WA, Yong KW, Poon CT, Noor Azmi MA, Omar SZ, Chua KH, Xu F, Wan Safwani WK (2015) In situ normoxia enhances survival and proliferation rate of human adipose tissue-derived stromal cells without increasing the risk of tumourigenesis. PLoS One 10(1):e0115034
Heathman TR, Nienow AW, McCall MJ, Coopman K, Kara B, Hewitt CJ (2015) The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen Med 10(1):49–64
Rowley J, Abraham E, Campbell A, Brandwein H, Oh S (2012) Meeting lot-size challenges of manufacturing adherent cells for therapy. BioProcess Int 10(3):7
Roemeling-van Rhijn M, de Klein A, Douben H, Pan Q, van der Laan LJ, Ijzermans JN, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ (2013) Culture expansion induces non-tumorigenic aneuploidy in adipose tissue-derived mesenchymal stromal cells. Cytotherapy 15(11):1352–1361
Rosland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, Mysliwietz J, Tonn JC, Goldbrunner R, Lonning PE, Bjerkvig R, Schichor C (2009) Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69(13):5331–5339
Moll G, Alm JJ, Davies LC, von Bahr L, Heldring N, Stenbeck-Funke L, Hamad OA, Hinsch R, Ignatowicz L, Locke M, Lonnies H, Lambris JD, Teramura Y, Nilsson-Ekdahl K, Nilsson B, Le Blanc K (2014) Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells 32(9):2430–2442
Yong KW, Wan Safwani WK, Xu F, Wan Abas WA, Choi JR, Pingguan-Murphy B (2015) Cryopreservation of human mesenchymal stem cells for clinical applications: current methods and challenges. Biopreserv Biobank 13(4):231–239
Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JA (2015) Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology 71(2):181–197
Rowley SD (1992) Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1(3):233–250
Davies OG, Smith AJ, Cooper PR, Shelton RM, Scheven BA (2014) The effects of cryopreservation on cells isolated from adipose, bone marrow and dental pulp tissues. Cryobiology 69(2):342–347
Hubel A (1997) Parameters of cell freezing: implications for the cryopreservation of stem cells. Transfus Med Rev 11(3):224–233
Hubel A (2011) Advancing the preservation of cellular therapy products. Transfusion 51(4):1537–2995
Stubban C, Katkov I, Loring JF, Wesselschmidt RL (2007) Cryopreservation of human embryonic stem cells. In: Loring JF, Wesselschmidt RL, Schwartz PH (eds) Human stem cell manual. Academic, Oxford, pp 47–55
Baust JG (2006) Concepts in biopreservation. In: Baust JG, Baust JM (eds) Advances in biopreservation. CRC Press, Boca Raton, pp 1–14
Baust JM, Corwin WL, VanBuskirk R, Baust JG (2015) Biobanking: the future of cell preservation strategies. In: Feridoun KB (ed) Biobanking in the 21st century. Springer, Cham, pp 37–53
Baust JM (2006) Properties of cells and tissues influencing preservation outcome: molecular basis of preservation-induced cell death. In: Baust JG, Baust JM (eds) Advances in biopreservation. CRC Press, Boca Raton, pp 63–88
Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16(4):557–564
Otto WR, Wright NA (2011) Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair 4(20):1755–1536
Wang S, Qu X, Zhao RC (2012) Clinical applications of mesenchymal stem cells. J Hematol Oncol 5(19):1756–8722
Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R, Kurtzberg J (2011) Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 17(4):534–541
Kurtzberg J, Prockop S, Teira P, Bittencourt H, Lewis V, Chan KW, Horn B, Yu L, Talano JA, Nemecek E, Mills CR, Chaudhury S (2014) Allogeneic human mesenchymal stem cell therapy (remestemcel-L, prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biol Blood Marrow Transplant 20(2):229–235
Kebriaei P, Isola L, Bahceci E, Holland K, Rowley S, McGuirk J, Devetten M, Jansen J, Herzig R, Schuster M, Monroy R, Uberti J (2009) Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 15(7):804–811
Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54(24):2277–2286
Vaes B, Van’t Hof W, Deans R, Pinxteren J (2012) Application of multiStem ((R)) allogeneic cells for immunomodulatory therapy: clinical progress and pre-clinical challenges in prophylaxis for graft versus host disease. Front Immunol 3(345):1–9
Guven S, Demirci U (2012) Integrating nanoscale technologies with cryogenics: a step towards improved biopreservation. Nanomedicine (London, England) 7(12):1787–1789
Hubel A, Spindler R, Skubitz AP (2014) Storage of human biospecimens: selection of the optimal storage temperature. Biopreserv Biobank 12(3):165–175
Zhang X, Catalano PN, Gurkan UA, Khimji I, Demirci U (2011) Emerging technologies in medical applications of minimum volume vitrification. Nanomedicine (London, England) 6(6):1115–1129
Janz Fde L, Debes Ade A, Cavaglieri Rde C, Duarte SA, Romao CM, Moron AF, Zugaib M, Bydlowski SP (2012) Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J Biomed Biotechnol 2012:649353
Wowk B (2012) Electric and magnetic fields in cryopreservation. Cryobiology 64(3):301–303; author reply 304–305
Lee SY, Huang GW, Shiung JN, Huang YH, Jeng JH, Kuo TF, Yang JC, Yang WC (2012) Magnetic cryopreservation for dental pulp stem cells. Cells Tissues Organs 196(1):23–33
McGann LE (1978) Differing actions of penetrating and nonpenetrating cryoprotective agents. Cryobiology 15(4):382–390
Rudolph AS, Crowe JH (1985) Membrane stabilization during freezing: the role of two natural cryoprotectants, trehalose and proline. Cryobiology 22(4):367–377
Karlsson JO (2002) Cryopreservation: freezing and vitrification. Science 296(5568):655–656
Karlsson JO, Toner M (1996) Long-term storage of tissues by cryopreservation: critical issues. Biomaterials 17(3):243–256
Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ (2007) Cryopreservation of hematopoietic stem cells. Am J Hematol 82(6):463–472
Shivakumar SB, Bharti D, Jang SJ, Hwang SC, Park JK, Shin JK, Byun JH, Park BW, Rho GJ (2015) Cryopreservation of human Wharton’s jelly-derived mesenchymal stem cells following controlled rate freezing protocol using different cryoprotectants; a comparative study. Int J Stem Cells 8(2):155–169
Liu G, Zhou H, Li Y, Li G, Cui L, Liu W, Cao Y (2008) Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells. Cryobiology 57(1):18–24
Miranda-Sayago JM, Fernandez-Arcas N, Benito C, Reyes-Engel A, Herrero JR, Alonso A (2012) Evaluation of a low cost cryopreservation system on the biology of human amniotic fluid-derived mesenchymal stromal cells. Cryobiology 64(3):160–166
Zhang HT, Chen H, Zhao H, Dai YW, Xu RX (2011) Neural stem cells differentiation ability of human umbilical cord mesenchymal stromal cells is not altered by cryopreservation. Neurosci Lett 487(1):118–122
Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G (1998) Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 18(6B):4705–4708
Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P (2000) Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 25(12):1299–1301
Windrum P, Morris TC (2003) Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 31(4):315
Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370
Tuschong L, Soenen SL, Blaese RM, Candotti F, Muul LM (2002) Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 13(13):1605–1610
Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A (2000) Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 49(3):152–156
Balci D, Can A (2013) The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking. Curr Stem Cell Res Ther 8(1):60–72
Rall WF, Fahy GM (1985) Ice-free cryopreservation of mouse embryos at −196 degrees C by vitrification. Nature 313(6003):573–575
Hunt CJ (2011) Cryopreservation of human stem cells for clinical application: a review. Transfus Med Hemother 38(2):107–123
Moon JH, Lee JR, Jee BC, Suh CS, Kim SH, Lim HJ, Kim HK (2008) Successful vitrification of human amnion-derived mesenchymal stem cells. Hum Reprod 23(8):1760–1770
Massood E, Maryam K, Parvin S, Mojgan M, Noureddin NM (2013) Vitrification of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells. Cryo Letters 34(5):471–480
Wu Y, Wen F, Gouk SS, Lee EH, Kuleshova L (2015) Cryopreservation strategy for tissue engineering constructs consisting of human mesenhymal stem cells and hydrogel biomaterials. Cryo Letters 36(5):325–335
Shi M, Ling K, Yong KW, Li Y, Feng S, Zhang X, Pingguan-Murphy B, Lu TJ, Xu F (2015) High-throughput non-contact vitrification of cell-laden droplets based on cell printing. Sci Rep 5(17928)
Li Y, Tan JC, Li LS (2010) Comparison of three methods for cryopreservation of human embryonic stem cells. Fertil Steril 93(3):999–1005
Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM, Irwin D, Blair S, Gorman AM, Patterson KG et al (1995) Hepatitis B transmission from contaminated cryopreservation tank. Lancet 346(8968):137–140
Fountain D, Ralston M, Higgins N, Gorlin JB, Uhl L, Wheeler C, Antin JH, Churchill WH, Benjamin RJ (1997) Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion 37(6):585–591
AbdelHafez F, Xu J, Goldberg J, Desai N (2011) Vitrification in open and closed carriers at different cell stages: assessment of embryo survival, development, DNA integrity and stability during vapor phase storage for transport. BMC Biotechnol 11(29):1472–6750
Song YS, Adler D, Xu F, Kayaalp E, Nureddin A, Anchan RM, Maas RL, Demirci U (2010) Vitrification and levitation of a liquid droplet on liquid nitrogen. Proc Natl Acad Sci U S A 107(10):4596–4600
Martin-Ibanez R, Hovatta O, Canals JM (2012) Cryopreservation of human pluripotent stem cells: are we going in the right direction? In: Katkov II (ed) Current frontiers in cryobiology. InTech, Rijeka, pp 139–166
Fraser JK, Cairo MS, Wagner EL, McCurdy PR, Baxter-Lowe LA, Carter SL, Kernan NA, Lill MC, Slone V, Wagner JE, Wallas CH, Kurtzberg J (1998) Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother 7(6):521–561
Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 92(22):10119–10122
Thirumala S, Goebel WS, Woods EJ (2009) Clinical grade adult stem cell banking. Organogenesis 5(3):143–154
Son JH, Heo YJ, Park MY, Kim HH, Lee KS (2010) Optimization of cryopreservation condition for hematopoietic stem cells from umbilical cord blood. Cryobiology 60(3):287–292
Thirumala S, Wu X, Gimble JM, Devireddy RV (2010) Evaluation of polyvinylpyrrolidone as a cryoprotectant for adipose tissue-derived adult stem cells. Tissue Eng Part C Methods 16(4):783–792
Rao W, Huang H, Wang H, Zhao S, Dumbleton J, Zhao G, He X (2015) Nanoparticle-mediated intracellular delivery enables cryopreservation of human adipose-derived stem cells using trehalose as the sole cryoprotectant. ACS Appl Mater Interfaces 7(8):5017–5028
Verdanova M, Pytlik R, Kalbacova MH (2014) Evaluation of sericin as a fetal bovine serum-replacing cryoprotectant during freezing of human mesenchymal stromal cells and human osteoblast-like cells. Biopreserv Biobank 12(2):99–105
Yong KW, Pingguan-Murphy B, Xu F, Abas WA, Choi JR, Omar SZ, Azmi MA, Chua KH, Wan Safwani WK (2015) Phenotypic and functional characterization of long-term cryopreserved human adipose-derived stem cells. Sci Rep 5:9596
Diaferia GR, Dessi SS, Deblasio P, Biunno I (2008) Is stem cell chromosomes stability affected by cryopreservation conditions? Cytotechnology 58(1):11–16
Jenkins EC, Ye L, Silverman WP (2012) Does the cryogenic freezing process cause shorter telomeres? Cryobiology 65(1):72–73
de Lima Prata K, de Santis GC, Orellana MD, Palma PV, Brassesco MS, Covas DT (2012) Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions. Cytotherapy 14(6):694–700
Luetzkendorf J, Nerger K, Hering J, Moegel A, Hoffmann K, Hoefers C, Mueller-Tidow C, Mueller LP (2015) Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation. Cytotherapy 17(2):186–198
Angelo PC, Ferreira AC, Fonseca VD, Frade SP, Ferreira CS, Malta FS, Pereira AK, Leite HV, Brum AP, Pardini VC, Gomes KB, Cabral AC (2012) Cryopreservation does not alter karyotype, multipotency, or NANOG/SOX2 gene expression of amniotic fluid mesenchymal stem cells. Genet Mol Res GMR 11(2):1002–1012
Yong KW, Safwani WK, Xu F, Zhang X, Choi JR, Abas WA, Omar SZ, Azmi MA, Chua KH, Pingguan-Murphy B (2016) Assessment of tumourigenic potential in long-term cryopreserved human adipose-derived stem cells. J Tissue Eng Regen Med 12(10)
Parmegiani L, Cognigni GE, Filicori M (2009) Ultra-violet sterilization of liquid nitrogen prior to vitrification. Hum Reprod 24(11):2969
Rollig C, Babatz J, Wagner I, Maiwald A, Schwarze V, Ehninger G, Bornhauser M (2002) Thawing of cryopreserved mobilized peripheral blood – comparison between waterbath and dry warming device. Cytotherapy 4(6):551–555
Thirumala S, Zvonic S, Floyd E, Gimble JM, Devireddy RV (2005) Effect of various freezing parameters on the immediate post-thaw membrane integrity of adipose tissue derived adult stem cells. Biotechnol Prog 21(5):1511–1524
Acknowledgements
This report was supported by University of Malaya Research Grant (UMRG RP040B-15HTM) from the Ministry of Education Malaysia.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Yong, K.W., Choi, J.R., Wan Safwani, W.K.Z. (2016). Biobanking of Human Mesenchymal Stem Cells: Future Strategy to Facilitate Clinical Applications. In: Karimi-Busheri, F., Weinfeld, M. (eds) Biobanking and Cryopreservation of Stem Cells. Advances in Experimental Medicine and Biology, vol 951. Springer, Cham. https://doi.org/10.1007/978-3-319-45457-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-45457-3_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45455-9
Online ISBN: 978-3-319-45457-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)